Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease Progression and LCH[original query] |
|---|
| Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis. The European respiratory journal 2016 Apr . Mourah Samia, How-Kit Alexandre, Meignin Véronique, Gossot Dominique, Lorillon Gwenaël, Bugnet Emmanuelle, Mauger Florence, Lebbe Celeste, Chevret Sylvie, Tost Jörg, Tazi Abdellat |
| Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH. The American journal of surgical pathology 2018 Apr . McGinnis Lisa M, Nybakken Grant, Ma Lisa, Arber Daniel |
| BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2019 May 1093526619847859. Ozer Erdener, Sevinc Akin, Ince Dilek, Yuzuguldu Resmiye, Olgun N |
| BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy. Pediatric blood & cancer 2024 6 e31099. Chan-Juan Wang, Ting Zhu, Chen-Zi Zhao, Hua Cui, Dong Wang, Zi-Jing Zhao, Xiao-Tong Huang, Hua-Lin Li, Fei-Fei Liu, Rui Zhang, Zhi-Gang Li, Lei C |
- Page last reviewed:Feb 1, 2024
- Content source:

